Has Heidi Webb received payments from drug or device companies?

Yes. Drug and device makers reported $9,825 in general payments to Heidi Webb across 522 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Heidi Webb did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Heidi Webb come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Heidi Webb

Medical · Pittsburgh, PANPI 1316296551

Payments from drug & device makers

$9,825in general payments, 2019–2025

Across 522 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$1K
Bayer$958
Dexcom, Inc.$798
Lilly USA, LLC$785
Sanofi-aventis U.S. LLC$769
Boehringer Ingelheim$718
plus $5K from 40 others

What the payments were for

Food & beverage$9,783100%
Education$420%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	78	$1,074
Bayer	62	$958
Dexcom, Inc.	36	$798
Lilly USA, LLC	46	$785
Sanofi-aventis U.S. LLC	45	$769
Boehringer Ingelheim	44	$718
Amgen	28	$541
Abbott	15	$525
AstraZeneca(2 entities)	12	$468
Corcept Therapeutics	12	$407
AbbVie	18	$299
BD	10	$246
Amneal Pharmaceuticals LLC	11	$197
Xeris Pharmaceuticals, Inc.	13	$190
Insulet Corporation	10	$173
Mannkind Corporation	7	$145
Medtronic	4	$109
Neurocrine Biosciences, Inc.	4	$108
Esperion Therapeutics, Inc.	1	$91
Antares Pharma, Inc.	4	$80
Kowa Pharmaceuticals America, Inc.	5	$79
Merck	4	$76
E.r. Squibb & Sons, L.L.C.	4	$72
Ultragenyx Pharmaceutical Inc.	4	$70
Ascendis Pharma Endocrinology Inc	3	$67
Tandem Diabetes Care, Inc.	4	$66
Amphastar Pharmaceuticals, Inc.	4	$65
Embecta Corp.	2	$60
Zealand Pharma US, Inc.	3	$60
Sequel Med Tech, LLC	3	$55
Pfizer	2	$44
Arbor Pharmaceuticals, Inc.	2	$39
GSK	2	$39
Radius Health, Inc.	2	$39
Amarin Pharma, Inc.	2	$36
Johnson & Johnson	2	$35
Cequr Corporation	2	$34
Kyowa Kirin, Inc.	2	$33
Novartis	2	$32
Averitas Pharma Inc.	1	$30
Acerus Pharmaceuticals Corporation	2	$29
Endo Pharmaceuticals Inc.	1	$22
BETA Bionics, Inc.	1	$17
Nevro Corp.	1	$17
Madrigal Pharmaceuticals	1	$15
IBSA Pharma Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,825 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	112	$116,045
TrulicityDulaglutide	89	$89,343
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog	45	$81,972
TradjentaLinagliptin	87	$68,157
MounjaroTirzepatide	62	$62,023
JardianceEmpagliflozin	72	$47,169
FarxigaDapagliflozin Propanediol	43	$36,291
Tresiba Flextouch U-200Insulin Degludec	23	$32,879
Humalog Kwikpen U-100Insulin Lispro	58	$24,821
RybelsusSemaglutide	21	$19,200
Janumet XrSitagliptin Phos/Metformin Hcl	21	$14,480
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog	15	$13,213
EliquisApixaban	19	$12,802
SynthroidLevothyroxine Sodium	153	$10,697
Tresiba Flextouch U-100Insulin Degludec	12	$8,137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Humalog	$785	$157,594168 claims
Novo NordiskOzempic, Rybelsus	$1,074	$135,245133 claims
Boehringer IngelheimTradjenta, Jardiance	$718	$115,326159 claims
AstraZenecaFarxiga	$468	$36,29143 claims
MerckJanumet Xr	$76	$14,48021 claims
PfizerEliquis	$44	$12,80219 claims
AbbVieSynthroid	$299	$10,697153 claims
Johnson & JohnsonXarelto	$35	$6,82412 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid	$197	$2,070159 claims
Sanofi-aventis U.S. LLCLantus	$769	$1,93111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Pittsburgh

Patrick OffiPittsburgh$63K
Haley WhitePittsburgh$34K
Allyson Zella PraterPittsburgh$32K
Braeden BashPittsburgh$27K
Caroline O'NeilPittsburgh$25K
Michael TometskoPittsburgh$16K
Tori PipakPittsburgh$15K
Juliette Bender HeinePittsburgh$15K
Aimee HerringtonPittsburgh$14K
Sarah AbrahamPittsburgh$14K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →